Whole-body Magnetic Resonance Imaging: Techniques, Clinical Indications, and Future Applications

Richard E. A Walker; Stephen J. Eustace

doi:10.1055/s-2001-12923

Seminars in Musculoskeletal Radiology, Inhaltsverzeichnis

Semin Musculoskelet Radiol 2001; 05(1): 005-020
DOI: 10.1055/s-2001-12923

Whole-body Magnetic Resonance Imaging: Techniques, Clinical Indications, and Future Applications

Richard E. A. Walker¹ , Stephen J. Eustace²

¹Boston University School of Medicine and Boston Medical Center, Boston, MA
²Mater Misericordiae & Cappagh National Orthopaedic Hospitals, Dublin, Ireland

Abstract

ABSTRACT

This article reviews developments in both pulse sequence design and gradient technology that facilitate rapid imaging of the whole body. It discusses its application in patients with bone marrow neoplasms, including metastases, lymphoma, and myeloma and emphasizes the value of whole-body magnetic resonance imaging in patients with known vertebral lesions to detect other bone lesions that are easier to biopsy. It outlines possible applications in well-defined clinical situations, including pregnancy and unknown primary tumor.

KEYWORD

Whole-body magnetic resonance imaging - metastasis - myeloma - lymphoma

Volltext

Referenzen

REFERENCES

1 Johnson K MR, Leavitt J D, Kayser H WM. Total body MR imaging in as little as 18 seconds. Radiology . 1997; 202 262-267
2 Edelman R R, Wieelopolski P, Schmitt F. Echo planar MR imaging. Radiology . 1994; 192 600-612
3 Hennig J, Naurth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med . 1986; 3 823-833
4 Brown M A, Semelka R C. MR imaging abbreviations, definitions, and descriptions: a review. Radiology . 1999; 213 647-662
5 Tang Y, Yamashita Y, Namimoto T. Liver T2-weighted MR imaging: Comparison of fast and conventional half Fourier single shot turbo spin-echo, breath hold turbo spin-echo and respiratory-triggered turbo spin-echo sequences. Radiology . 1997; 203 776-772
6 Reeder S B, McVeigh E R. Effect of high performance gradients on fast greadient echo imaging. Magn Reson Med . 1994; 32 612-615
7 Eustace S, Walker R, Blake M. Whole-body MR imaging: practical issues, clinical applications, and future directions. MRI Clin North Am . 1999; 7 209-236
8 Gold R I, Seeger L L, Bassett L W. An integrated approach to the evaluation of metastatic bone disease. Radiol Clin North Am . 1990; 28 471-483
9 Bretill J. Skeletal scintigraphy for the diagnosis of malignant disease to bone. In: Goris ML, ed. Sensitivity and Specificity of Common Scintigraphic Procedures London: Year Book Medical Publishers 1985: 49-67
10 Gosfield E, Alavi A, Kneeland B. Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases. J Nucl Med . 1993; 34 2192-2198
11 Krishnamurthy G T, Tubis M, Hiss J. Distribution pattern of metastatic bone disease: a need for total body skeletal image. JAMA . 1977; 237 2504-2506
12 Martin W H, Delbeke D, Patton J A. Detection of malignancies with SPECT versus PET, with 2-[flourine-18] fluoro-2-deoxy-d-glucose. Radiology . 1996; 198 225-231
13 Aitchison F A, Poon F W, Hadley M D. Vertebral metastases and equivocal bone scan: value of magnetic resonance imaging. Nucl Med Com . 1992; 13 429-431
14 Delbeke D, Powers T A, Sandler M P. Negative scintigraphy with positive magnetic resonance imaging in bone metastases. Skeletal Radiol . 1990; 19 113-116
15 Zimmer W D, Berquist T H, McLeod R A. Bone tumors: magnetic resonance imaging versus computed tomography. Radiology . 1985; 155 709-718
16 Gosfield E, Alavi A, Kneeland B. Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases. J Nucl Med . 1993; 34 2192-2198
17 Avrahami E, Tadmor R, Dally O. Early MR demonstration of spinal metastases in patients with normal radiographs and CT and radionuclide bone scans. J Comput Assist Tomogr . 1989; 13 598-602
18 Frank J A, Ling A, Patronas N J. Detection of malignant bone tumors: MR imaging versus scintigraphy. Am J Roentgenol . 1990; 155 1043-1048
19 Fujii Y, Higashi Y, Owada F. MR imaging for the diagnosis of prostate cancer metastatic to bone. Br J Urol . 1995; 75 54-58
20 Flickinger F W, Salahattin S M. Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases. Magn Reson Imaging . 1994; 12 829-835
21 Constable R T, Smith R C, Gore J C. Signal to noise and contrast in fast spin echo (FSE) and inversion recovery FSE imaging. J Comput Assist Tomogr . 1992; 16 41-47
22 Jones K M, Unger E C, Granstrom P, et al Bone marrow imaging using STIR at 0.5 Tesla and 1.5 Tesla. Magn Reson Imaging . 1992; 10 169-176
23 Mirowitz S A, Apicella P, Reinus W R. MR imaging of bone marrow lesions: Relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. Am J Roentgenol . 1994; 162 215-221
24 Algra P R, Bloem J L, Tissing H. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics . 1991; 11 219-232
25 Hoane B R, Shields A F, Porter B A. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood . 1991; 78 728-738
26 Eustace S, Tello R, DeCarvalho V. A comparison of whole-body turbo short tau inversion recovery MR imaging and planar technetium 99m methylene diphosphonate scintigraphy in the evaluation of patients with suspected skeletal metastases. Am J Roentgenol . 1997; 169 1655-1661
27 Eustace S, Tello R, DeCarvalho V. Whole-body MR imaging versus isotope bone scanning for metastases. Am J Roentgenol . 1998; 171 519-520
28 Dohner H, Guckel F, Knauf W. Magnetic resonance imaging in of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy. Br J of Haematol . 1989; 73 12-17
29 Hayward J L, Carbone P P, Heuson J C. Assessment of response to therapy in advanced breast cancer. Eur J Cancer . 1979; 13 89-94
30 Hortobagyi G N, Libshitz H I, Seabold J E. Osseous metastases of breast cancer. Clinical, biochemical, radiographic and scintigraphic evaluations of response to therapy. Cancer . 1984; 53 577-582
31 Linden A, Zankovich R, Theissen P. Malignant lymphoma: bone marrow imaging versus biopsy. Radiology . 1989; 173 335-339
32 Porter B A, Shields A F, Olson D O. Magnetic resonance imaging of bone marrow disorders. Radiol Clin North Am . 1986; 24 269-289
33 Smoker W RK, Godersky J C, Knutzon R K. The role of MR imaging in evaluating metastatic spinal disease. Am J Roentgenol . 1987; 149 1241-1248
34 Forster J H. Survival after liver resection for secondary tumors. Am J Surg . 1978; 135 389-394
35 Jardines L, Callans L S, Torosain M H. Recurrent breast cancer: Presentations, diagnosis, and treatment. Semin Oncol . 1993; 20 538-547
36 Bydder G M, Hajnal J V, Young I R. MRI: use of the inversion recovery pulse sequence. Clin Radiol . 1998; 53 159-176
37 Smith R C, Reinhold C, Lange R C. Fast spin echo STIR imaging. Radiology . 1992; 184 665-669
38 Daffner R, Lupetin A, Dash N. MRI in the detection of malignant infiltration of bone marrow. Am J Roentgenol . 1986; 146 353-358
39 Zimmer W D, Berquist T H, McLeod R A. Bone tumors: magnetic resonance imaging versus computed tomography. Radiology . 1985; 155 709-718
40 Dwyer A J, Franf J A, Sank V J. Short T-1 inversion recovery pulse sequence: analysis and initial experience in cancer imaging. Radiology . 1988; 168 827-836
41 Hankelman R M, Hardy P, Poon P Y. Optimal pulse sequence for imaging hepatic metastases. Radiology . 1986; 161 727-734
42 Gaa J, Hatabu H, Jenkins R L. Liver masses: replacement of conventional T2-weighted spin echo MR imaging with breath hold MR imaging. Radiology . 1996; 200 459-464
43 Melhem E R, Jara H, Shakir H. Fast inversion recovery MR imaging: the effect of hybrid RARE read out on the null points of CSF and fat. Am J Neuroradiol . 1997; 18 1627-1633
44 Karsell P R, Sheeny P F, O'Connell M. Computed tomography in search of cancer of unknown origin. JAMA . 1982; 248 340-343
45 Moertel C G, Reitmeier R J, Schutt A J. Treatment of patients with adenocarcinoma of unknown origin. Cancer . 1972; 30 1469-1472
46 Abbruzzese J L, Abbruzzese M C, Lenzi R. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol . 1995; 13 2094-2103
47 Le Cesne A, Le Chevalier T, Caille P. Metastases from cancers of unknown primary site: data from 302 autopsies. Presse Med . 1991; 29 1369-1373
48 Schapira D V, Jarrett A R. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med . 1995; 155 2050-2054
49 Hainsworth J D. Treating advanced cancer in an era of increasing cost consciousness. Arch Intern Med . 1995; 155 2035-2036
50 Eustace S, Tello R, Yucel E K. Whole-body turbo STIR MR imaging in unknown primary tumor detection. J Magn Reson Imaging . 1998; 8 751-753
51 Durie B GM, Salmon S E. A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer . 1975; 36 842-854
52 Olson P, Everson L I, Griffiths H J. Staging of musculoskeletal tumors. Radiol Clin North Am . 1994; 32 151-162
53 Staebler A, Baur A, Bartl R. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. Am J Roentgenol . 1996; 167 1029-1036
54 Smith D B, Scarffe J H, Eddleston B. The prognostic significance of x-ray changes at presentation and reassessment in patients with multiple myeloma. Hematol Oncol . 1988; 6 1
55 Bellaiche L, Laredo J D, Liote F. Magnetic resonance appearance of monoclonal gammopathies of unknown significance and multiple myeloma. Spine . 1997; 22 2551-2557
56 Carlson K, Astrom R, Nyman H. MR imaging of multiple myeloma in tumour mass measurement at diagnosis and during treatment. Acta Radiolog . 1995; 36 9-14
57 Vande Berg C B, Lecouvet F E, Michaux L. Stage 1 multiple myeloma: Value of MR imaging of the bone marrow in the determination of prognosis. Radiology . 1996; 201 243-246
58 Vande Berg C B, Michaux L, Lecouvet F E. Nonmyelomatous monoclonal gammopathy: Correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology . 1997; 202 247-251
59 Moulopoulos L A, Dimopoulos M A, Alexanian R. Multiple Myeloma: MR patterns of response to treatment. Radiology . 1994; 193 441-446
60 Moulopoulos L A, Dimopoulos M A. Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood . 1997; 90 2127-2147
61 Logan P M, Connell D G, O'Connell J X. Image guided percutaneous biopsy of musculoskeletal tumors: algorithm for selection of specific biopsy techniques. Am J Roentgenol . 1996; 166 137-142